Apexigen
patient case study significant response to combination lasting years | Apexigen
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
16 of 27
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
overview she toe phosphate vaginal gel is a antibacterial indicated for the treatment of bacterial in female patients years of age and older this marks the first approved product in dar portfolio of potential first in category development candidates first commercial sale anticipated in the | Dare Bioscience
Theravance Biopharma
Investor Conference
November 2022
new study in patients with cypress | Theravance Biopharma
Genprex
Investor Presentation
November 2024
diabetic patients are in need of advanced therapy | Genprex
Talkspace
SPAC
January 2021
unique platform to match providers and patients years | Talkspace
Other recent decks by Apexigen
See all presentations (2 decks)
SPAC
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io